Pearl River Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-18,395
| Closed | -$764K | – | 53 |
|
2024
Q2 | $764K | Buy |
+18,395
| New | +$764K | 0.12% | 219 |
|
2024
Q1 | – | Sell |
-61,801
| Closed | -$3.17M | – | 479 |
|
2023
Q4 | $3.17M | Buy |
+61,801
| New | +$3.17M | 0.51% | 44 |
|
2023
Q3 | – | Sell |
-17,051
| Closed | -$1.09M | – | 498 |
|
2023
Q2 | $1.09M | Sell |
17,051
-6,161
| -27% | -$394K | 0.18% | 185 |
|
2023
Q1 | $1.61M | Sell |
23,212
-88,344
| -79% | -$6.12M | 0.26% | 121 |
|
2022
Q4 | $8.03M | Buy |
+111,556
| New | +$8.03M | 1.36% | 2 |
|
2022
Q1 | – | Sell |
-24,483
| Closed | -$1.53M | – | 407 |
|
2021
Q4 | $1.53M | Sell |
24,483
-49,049
| -67% | -$3.06M | 0.41% | 67 |
|
2021
Q3 | $4.35M | Buy |
73,532
+68,655
| +1,408% | +$4.06M | 1.18% | 8 |
|
2021
Q2 | $326K | Buy |
+4,877
| New | +$326K | 0.09% | 307 |
|
2021
Q1 | – | Sell |
-13,170
| Closed | -$817K | – | 396 |
|
2020
Q4 | $817K | Buy |
+13,170
| New | +$817K | 0.29% | 119 |
|
2020
Q2 | – | Sell |
-6,658
| Closed | -$371K | – | 311 |
|
2020
Q1 | $371K | Buy |
6,658
+1,825
| +38% | +$102K | 0.72% | 29 |
|
2019
Q4 | $310K | Buy |
+4,833
| New | +$310K | 0.12% | 327 |
|
2019
Q3 | – | Sell |
-2,647
| Closed | -$120K | – | 425 |
|
2019
Q2 | $120K | Sell |
2,647
-2,577
| -49% | -$117K | 0.77% | 55 |
|
2019
Q1 | $250K | Buy |
+5,224
| New | +$250K | 0.62% | 16 |
|